Índices de fibrosis en el seguimiento de la enfermedad hepática grasa no alcohólica

Gil Guirado, Liliyisel; Morales Martínez, Ignacio; Coronado Herrera, Yohana; Botello Ramírez, Emilia A; Broche Manso, Yanivys; Puerto Díaz, Margarita.
Medicentro (Villa Clara) ; 27(3)sept. 2023.
Artigo em Espanhol | LILACS | ID: biblio-1514482

Documentos relacionados

  1. [Obesity-fatty liver: the role of the pediatrician].
  2. Non-alcoholic fatty liver disease - a procoagulant condition?
  3. Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician's Guide.
  4. En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH.
  5. 'Mistakes in managing non-alcoholic fatty liver disease and how to avoid them'.
  6. Enfermedad hepática grasa no alcohólica en personas no obesas: revisión narrativa de la literatura
  7. Towards precision medicine in non-alcoholic fatty liver disease.
  8. Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patients.
  9. Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients.
  10. Advanced liver fibrosis and the metabolic syndrome in a primary care setting.